Discontinuation report 0.9% SODIUM CHLORIDE INJECTION, USP
Report ID | 120952 |
Drug Identification Number | 00060208 |
Brand name | 0.9% SODIUM CHLORIDE INJECTION, USP |
Common or Proper name | 0.9% Sodium Chloride Injection, USP, 250 mL |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 900MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 250 mL AVIVA Container (JE1322) |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | 2019-05-07 |
Actual discontinuation date | 2019-05-07 |
Remaining supply date | 2019-05-07 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-07-23 | French | Compare |
v1 | 2020-07-23 | English | Compare |
Showing 1 to 2 of 2